Key Takeaways
Extended Takeaways
- In this primary care sample, 94.0% of participants had at least mild anxiety on the HAM-A, with 44.0% in the moderate-to-severe range, underscoring that clinically meaningful anxiety burden was common even among patients without prior GAD diagnosis or current psychiatric pharmacotherapy.
- Psychosocial stress showed the strongest association with anxiety severity in the analysis (OR =124.6; 99% CI, 29.3–529.6; P<.001), so pairing anxiety screening with a brief stress measure such as the PSS may help identify patients most likely to have more severe symptoms.
- Lifetime anxiety episodes and panic attacks clustered heavily with higher anxiety severity: among patients with moderate-to-severe anxiety, 85.7% reported anxiety episodes and 90.0% reported panic attacks, which can help clinicians prioritize diagnostic clarification when these histories are elicited in primary care.
- A history of SARS-CoV-2 infection was present in 47.27% of participants and was associated with anxiety severity (OR=1.9; 99% CI, 1.2–3.1; P < .001), suggesting that post-COVID clinical histories should routinely include anxiety assessment in community settings.
- Smoking habits, illicit substance use, personal history of depression, traumatic childhood event, and medical comorbidities were not significantly associated with anxiety severity in this sample, which may help clinicians avoid over-weighting these factors relative to the stronger correlates identified here.
- Only 10% of the sample reported traumatic brain injury, and no cases in that subgroup had moderate-to-severe anxiety; the authors did not perform bivariate or logistic analyses for this variable because of the small and likely unrepresentative sample, so these data should not be used to infer a protective effect.